» Articles » PMID: 33373484

Peripheral Guanylate Cyclase-C Modulation of Corticolimbic Activation and Corticotropin-releasing Factor Signaling in a Rat Model of Stress-induced Colonic Hypersensitivity

Overview
Date 2020 Dec 29
PMID 33373484
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Psychological stress is a risk factor for irritable bowel syndrome, a functional gastrointestinal pain disorder featuring abnormal brain-gut connectivity. The guanylate cyclase-C (GC-C) agonist linaclotide has been shown to relieve abdominal pain in IBS-C and exhibits antinociceptive effects in rodent models of post-inflammatory visceral hypersensitivity. However, the role GC-C signaling plays in psychological stress-induced visceral hypersensitivity is unknown. Here, we test the hypothesis that GC-C agonism reverses stress-induced colonic hypersensitivity via inhibition of nociceptive afferent signaling resulting in normalization of stress-altered corticotropin-releasing factor (CRF) expression in brain regions involved in pain perception and modulation.

Methods: Adult female rats were exposed to water avoidance stress or sham stress for 10 days, and the effects of linaclotide on stress-induced changes in colonic sensitivity, corticolimbic phospho-extracellular signal-regulated kinase (pERK), and CRF expression were measured using a combination of behavioral assessments, immunohistochemistry, and qRT-PCR.

Key Results: Stressed rats exhibited colonic hypersensitivity and elevated corticolimbic pERK on day 11, which was inhibited by linaclotide. qRT-PCR analysis revealed dysregulated CRF expression in the medial prefrontal cortex, paraventricular nucleus of the hypothalamus, and central nucleus of the amygdala on day 28. Dysregulated CRF expression was not affected by linaclotide treatment.

Conclusions And Inferences: Our results demonstrate that exposure to repeated stress induces chronic colonic hypersensitivity in conjunction with altered corticolimbic activation and CRF expression. GC-C agonism attenuated stress-induced colonic hypersensitivity and ERK phosphorylation, but had no effect on CRF expression, suggesting the analgesic effects of linaclotide occur independent of stress-driven CRF gene expression in corticolimbic circuitry.

Citing Articles

Research Progress of Central and Peripheral Corticotropin-Releasing Hormone in Irritable Bowel Syndrome with Comorbid Dysthymic Disorders.

Liang Y, Chen X, Zhang M, Tang H, Shen G Gut Liver. 2023; 18(3):391-403.

PMID: 37551453 PMC: 11096901. DOI: 10.5009/gnl220346.


Receptor Guanylyl Cyclase C and Cyclic GMP in Health and Disease: Perspectives and Therapeutic Opportunities.

Prasad H, Mathew J, Visweswariah S Front Endocrinol (Lausanne). 2022; 13:911459.

PMID: 35846281 PMC: 9276936. DOI: 10.3389/fendo.2022.911459.


Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain.

Brierley S, Grundy L, Castro J, Harrington A, Hannig G, Camilleri M Trends Pharmacol Sci. 2021; 43(2):110-122.

PMID: 34865885 PMC: 8760167. DOI: 10.1016/j.tips.2021.11.002.


Environmental enrichment prevents stress-induced epigenetic changes in the expression of glucocorticoid receptor and corticotrophin releasing hormone in the central nucleus of the amygdala to inhibit visceral hypersensitivity.

Orock A, Louwies T, Ligon C, Mohammadi E, Greenwood-Van Meerveld B Exp Neurol. 2021; 345:113841.

PMID: 34390704 PMC: 8953442. DOI: 10.1016/j.expneurol.2021.113841.